Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Random Mutagenesis And Amplification Of Nucleic Acid

a nucleic acid and mutagenesis technology, applied in combinational chemistry, dna preparation, library creation, etc., can solve the problems of tertiary structure, biological function remains elusive, and formidable tasks, and achieve the goal of promoting heterologous binding of oligonucleotides, enhancing degeneracy of oligonucleotides, and increasing the efficiency of extension of oligonucleotides

Inactive Publication Date: 2008-09-25
GENOPSYS
View PDF0 Cites 103 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0057]The library of oligonucleotides may optionally be synthetic and may be synthesized by randomly incorporating A, T, G, C, I or U. Optionally, at least one of the oligonucleotides used in the library of oligonucleotide in the above methods has one or more inosine residues at the 3′ end of the oligonucleotide, preferably 1-5 inosine residues, more preferably 2-4 inosine residues and most preferably 2 inosine residues. Incorporation of inosine into the oligonucleotide at the 3′ end is believed to enhance degeneracy of the oligonucleotide and promote heterologous binding of the oligonucleotide to the target sequence, which should increase the efficiency of the extension of the oligonucleotide by DNA polymerase.

Problems solved by technology

However, to a large extent, the correlation between protein primary sequence, tertiary structure, and biological function remains elusive.
Although it is desirable to be able to predict protein folding pattern from its primary sequence and to correlate its structure with function in vivo, in reality, this has proven to be a formidable task.
It is an important, but cumbersome approach to compiling an overall picture of protein functional character, let alone stability and regulatory characteristics in vivo.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Random Mutagenesis And Amplification Of Nucleic Acid
  • Random Mutagenesis And Amplification Of Nucleic Acid
  • Random Mutagenesis And Amplification Of Nucleic Acid

Examples

Experimental program
Comparison scheme
Effect test

example

[0166]The gene encoding a penicillinase from Bacillus licheniformis was used as a target to be randomly mutagenized. By randomly mutating the enzyme, isozymes which show altered hydrolytic activity and / or specificity against various penicillins and cephalosporins may offer clues to 1) how antibiotics can be designed to thwart the inevitable evolution towards β-lactamases which render pathogenic bacteria resistant to drug therapy, and 2) offer further information for the study of protein structure-function relationships.

[0167]The gene encoding the Bacillus licheniformis was isolated from a plasmid pELB1. The plasmid pELB1 is a pBR322 derivative, containing the “exolarge” form of the B. licheniformis b-lactamase gene, utilizing the Bacillus amyloliquefaciens promoter and subtilisin signal sequence, and Bacillus and E. coli origins of replication (Ellerby, L. M., Escobar, W. A., Fink, A. L., Mitchinson C., Wells J A (1990) Biochemistry, June 19; 29(24):5797-806).

[0168]pELB1 was digeste...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Timeaaaaaaaaaa
Login to View More

Abstract

A method is provided for mutagenizing nucleic acids and proteins relative to an initial nucleic acid sequence by the insertion, deletion or substitution of nucleotide(s) in the target nucleic acid during amplification.

Description

CROSS-REFERENCE[0001]This application is a divisional application of application Ser. No. 10 / 069,442, filed Jun. 28, 2008, which is a 371 of PCT / US00 / 22078, filed on Aug. 11, 2000, which is a continuation-in-part of application Ser. No. 09 / 374,274, filed on Aug. 13, 1999, now U.S. Pat. No. 6,251,604, which are incorporated herein by reference in their entirety.BACKGROUND OF THE INVENTION[0002]1. Field of the Invention[0003]The present invention relates to methods for mutagenizing nucleic acids and proteins. More particularly, the present invention relates to methods for mutagenizing nucleic acids and proteins relative to an initial target nucleic acid sequence by the insertion, deletion, or substitution of nucleotide(s) in the target nucleic acid during amplification.[0004]2. Description of Related Art[0005]The sequences of genes encoding many important proteins have been determined at a rapid speed owing to the fast progress in the field of genomics. The three-dimensional structure...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C40B50/06C12N9/86C12N15/10
CPCC12N15/1093C12N15/102
Inventor LIETZ, ERIC
Owner GENOPSYS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products